Home 
FOR AUTHORS General Physiology and Biophysics 2013 General Physiology and Biophysics Vol.32, No.4, p.459–466, 2013
FOR AUTHORS General Physiology and Biophysics 2013 General Physiology and Biophysics Vol.32, No.4, p.459–466, 2013
Journal info
Aims and Scope |
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
General Physiology and Biophysics Vol.32, No.4, p.459–466, 2013 |
||
| Title: Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis | ||
| Author: Lucia Krizova, Branislav Kollar, Daniela Jezova, Peter Turcani | ||
| Abstract: Recent findings suggest that polymorphisms in vitamin D pathway genes are candidates for association with multiple sclerosis susceptibility. It has been now well demonstrated that vitamin D has immunomodulatory functions that may be favorable for reduction of multiple sclerosis risk. Current research has been focused on identification of new variants of genes involved in vitamin D pathway, namely in vitamin D receptor and enzymes of vitamin D metabolism. These variants have been intensively studied as possible genetic predictors of both vitamin D levels and the risk of multiple sclerosis. Considering the findings available up-to-date, we may recognize two groups of genetic variants. The first group of genes was found to predict vitamin D levels but not the risk of multiple sclerosis. The second group of genetic variants is represented by promising genes predicting vitamin D levels as well as the risk of multiple sclerosis. A strong association with increased risk of the disease has been observed for a rare variant in the CYP27B1 gene encoding a vitamin D-activating enzyme. Observed interaction between genetic and epidemiological findings brings the rationale for supplementation trials of vitamin D. Although promising effects of vitamin D supplementation have emerged, the results obtained so far are inconclusive and the real therapeutic significance of vitamin D supplementation remains to be elucidated. |
||
| Keywords: Multiple sclerosis risk — Genetic variants — Vitamin D deficiency — Vitamin D supplementation | ||
| Year: 2013, Volume: 32, Issue: 4 | Page From: 459, Page To: 466 | |
| doi:10.4149/gpb_2013067 |
||
|
|
 download file |
|